• Latest Posts

Head and neck cancer data presented at ASCO 2023

Podcast 2 Jun 2023

Beyond Biotech podcast 48

Transgene and BioInvent report positive solid tumor results

Transgene approved for IV oncolytic virus trial

Transgene’s Cancer Vaccine Abandoned after Phase II Fail

RNA Therapies, Immunotherapies and Cancer Tests Showcased in Spain


Oncolytic Virus for Liver Cancer Ruled Futile in Phase III

In Depth 23 Jan 2018

Walking with the Dinosaurs of European Biotech: Which of Them is Roaring the Loudest?

Servier Recruits Viral Vector Expert to Step Up its CAR-T Technology

French Oncolytic Virus Vaccine for Breast Cancer enters Phase II

Transgene teams up with big Players against HPV Head and Neck Cancer

12 European Biotechs which ‘stole the show’ at World most Important Cancer Meeting